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Abstract: To visually and genetically trace single-cell dynamics of human prostate cancer (PCa) cells
at the early stage of metastasis, a zebrafish (ZF) xenograft model was employed. The phenotypes
of intravenously transplanted fluorescent cells were monitored by high-resolution, single-cell
intravital confocal and light-sheet imaging. Engrafted osteotropic, androgen independent PCa
cells were extravasated from caudle vein, invaded the neighboring tissue, proliferated and formed
experimental metastases around caudal hematopoietic tissue (CHT) in four days. Gene expression
comparison between cells in culture and in CHT revealed that engrafted PCa cells responded to
the ZF microenvironment by elevating expression of epithelial–mesenchymal transition (EMT) and
stemness markers. Next, metastatic potentials of ALDHhi cancer stem-like cells (CSCs) and ALDHlow
non-CSCs were analyzed in ZF. Engraftment of CSCs induced faster metastatic onset, however after
six days both cell subpopulations equally responded to the ZF microenvironment, resulting in the
same increase of stemness genes expression including Nanog, Oct-4 and Cripto. Knockdown of Cripto
significantly reduced the vimentin/E-cadherin ratio in engrafted cells, indicating that Cripto is required
for transduction of the microenvironment signals from the ZF niche to increase mesenchymal potential
of cells. Targeting of either Cripto or EMT transcriptional factors Snail 1 and Zeb1 significantly
suppressed metastatic growth. These data indicated that zebrafish microenvironment governed the
CSC/EMT plasticity of human PCa cells promoting metastasis initiation.
Keywords: Zebrafish xenograft model; prostate cancer; cell plasticity
1. Introduction
Prostate cancer (PCa) is one of the most prevalent cancer diseases in men around the world [1].
Between 20% and 30% of patients who originally respond to initial treatments can still develop
androgen-independent and treatment-resistant bone metastasis, which is the main cause of death.
Metastasis is a complex, multiple-step process led by intravasation of single cancer cells/clusters into
vasculature from the primary site [2]. After circulating in blood flow and extravasation, only very
few cancer cells that have homed and responded to the foreign microenvironment can eventually
develop metastatic tumor growth [3]. More recently, a small subpopulation of cancer cells called
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cancer stem-like cells (CSCs) have been indicated to initiate PCa bone metastasis [4,5]. Those cells are
characterized by high self-renewal capacity, tumorigenicity and chemoresistance. A number of proteins
are identified as PCa CSC markers including CD44, integrin α2β1 and aldehyde dehydrogenase
(ALDH) isoforms ALDH1A1 and ALDH7A1 [6–8]. Moreover, cell subpopulations with high ALDH
activity have been reported as CSC-enriched subpopulations and characterized by high expression
of CD44, integrin α2β1, enhanced clonogenicity in vitro and metastatic capacity in vivo [7]. Hence,
targeting of this cell subpopulation may have a positive clinical outcome. Importantly, it is suggested
that CSCs can be dedifferentiated from non-CSCs in multiple types of cancers including PCa [9–11].
This so-called CSC-plasticity is hypothetically driven by the molecular and cellular cues present in the
tumor microenvironment [3,9]. Understanding the underlying mechanisms driving cancer plasticity is,
therefore, essential for anti-CSC drug development.
The emergence of CSCs are closely linked to the epithelial–mesenchymal transition (EMT) [12–14],
a developmental program promoting cancer progression [15–17]. Once this happens, cancer cells
lose cell–cell junction, gain motility and induce metastatic dissemination [15]. Multiple studies have
indicated that the production of CSCs is partially a result of EMT [18]. Transient expression of EMT
transcriptional factors Snail1 can induce tumor recurrence and metastasis [19,20]. In addition, EMT is
a highly plastic process. Cancer cells can shift between EMT and its reversed program, mesenchymal
to epithelial transition (MET), at different steps of metastatic cascades, endowing the cells with distinct
properties like migration, invasion, quiescence and re-entry of tumor growth [21]. However, due to a
lack of tools to detect single-cell status at each step of the metastatic cascade, the precise roles of EMT
and MET in the whole metastatic process are still controversial [22].
Zebrafish (ZF) have been employed as a powerful platform for cancer research due to their
high genomic conservation with humans [23–25]. They are widely used to model the initiation and
malignant progression of different types of cancer [23,26,27]. ZF xenograft models with different
human cancer cells have been established [25,28]. Due to an absence of mature adaptive immunity at
the embryonic stage, human cancer cell lines and patient-derived primary cancer cells can survive,
grow and metastasize in ZF [26]. Optical transparency of the embryo enables imaging of all steps of
cancer progression at a single-cell resolution in the live animal. The high molecular similarity between
human and ZF permits the human cancer cells to sense and respond to ZF microenvironment cues
during cancer progression [29,30]. High-throughput screens can be easily performed to assess the
metastatic capacity of different cancer cells and to test their therapeutic responses to drugs [27].
To visually and genetically trace PCa cell plasticity at the early stagy of metastasis, fluorescence-
labeled PCa cells were intravenously injected into zebrafish, inducing formation of metastatic lesions
in the zebrafish hematopoietic tissue. Immunofluorescence and RT-PCR analysis revealed an induction
of EMT, enrichment of ALDHhi CSC subpopulation and upregulation of CSC markers when the PCa
cells colonized the metastatic site. We previously reported that Cripto is a stemness gene that governs
PCa metastasis in zebrafish and mice xenografts [31]. Furthermore, we observed that co-culturing
of PCa cells with osteoblasts induced Cripto expression, suggesting possible involvement of bone
niche signals in its regulation [31]. Here, we showed that the expression of Cripto in the engrafted
cells was upregulated by the ZF microenvironment. This microenvironment-induced Cripto drove
experimental metastatic colonization through induction of EMT plasticity. Targeting of either Cripto or
EMT transcriptional factors significantly inhibited metastatic growth. Altogether, our data indicated
that human PCa cells can respond to zebrafish molecular and cellular cues, inducing Cripto-mediated
EMT/CSC plasticity, which leads to metastatic tumor initiation.
2. Materials and Methods
2.1. Cell Culture
Human embryonic kidney cells HEK-293T (kindly provided by Dr. Sylvia Le Dévédec, Leiden
Academic Center for Drug Research, Leiden University, Leiden, Netherlands) were maintained in
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DMEM supplemented with 10% FCS. Human PCa cell line PC-3-mCherry was maintained in Nutrient
Mixture F-12K supplemented with 10% FCS, while PC-3M-Pro4-mCherry (kindly provided by Dr.
Gabriel van der Pluijm, Department of Urology, Leiden University Medical Center, Leiden, Netherlands)
was DMEM supplemented with 10% FCII (GE Healthcare Life Science, Pittsburgh, United States).
2.2. Zebrafish Maintenance, Tumor Cell Implantation and Metastasis Analysis
Wildtype zebrafish (ZF) line ABTL and transgenic line tg (Fli:GFP) [32] were handled in
compliance with local animal welfare regulations and maintained according to standard protocols
(www.ZFIN.org). Experiments were assessed by the Animal Experiments Committee (Dier Experimenten
Commissie—DEC) and assessed by the Central Committee on Animal Testing (CCD).
Cancer cell transplantation was performed as described before [28]. In brief, at two days post-
fertilization (dpf), dechorionated ZF embryos were anaesthetized with 0.003% tricaine (Sigma-Aldrich,
Zwijndrecht, Netherlands) and plated on a Petri dish covered with 1.5% of solidified agarose. Cancer
cells were trypsinized, suspended in PBS containing 2% polyvinylpyrrolidone (PVP; Sigma-Aldrich,
Zwijndrecht, Netherlands) with a concentration of 200,000 cells/uL and loaded in into borosilicate
glass capillary needles (1 mm O.D. × 0.78 mm I.D.; Harvard Apparatus, Holliston, MA, USA). Between
300 and 500 cancer cells labeled with either mCherry or Lifeact-mCherry were injected into the duct
of Cuvier (DoC) of ZF embryos using a Pneumatic Picopump and a manipulator (WPI). The injected
embryos were further maintained in a 34 ◦C incubator until the end of the experiments [28]. Images
were acquired with a Leica M165 FC stereo fluorescent microscope at 1, 2, 4 and/or 6 d post injection
(dpi). Intensity of mCherry fluorescence was further analyzed with image J software (IJ1.46r) and/or
the ZF4 pixel counting program (Leiden Institute of Advanced Computer Science, Leiden University,
Leiden, Netherlands). For high-resolution imaging, zebrafish embryos were placed on glass-bottom
petri dishes and covered with 1% low melting agarose containing 0.003% tricaine (Sigma-Aldrich,
Zwijndrecht, Netherlands). Images were acquired using a Leica SP8 confocal microscope (Leica
Microsystems B.V, Amsterdam, Netherlands) and processed with image J software (IJ1.46r).
For light-sheet microscopy, zebrafish embryos were anesthetized with 0.003% tricaine, embedded
in 1% low melting agarose with tricaine and mounted in Zeiss light-sheet Z.1 capillary specimen holder,
vertically immersed in imaging chamber containing water with tricaine. For whole-trunk imaging
(Figure 1b) and for single-cell imaging (Figure 1c) 20× and 40× objectives were used, respectively.
Specimens were imaged in single-track dual-channel mode to minimize spatial shift between channels.
For each area, four stacks were acquired with specimen axial rotation of 90◦ between stacks. Specimen
3D structure was reconstructed using multiview fusion and deconvolution (Zeiss ZEN software (blue
edition)). Surface rendering was performed using Imaris 8.1 with solid or semitransparent vasculature
to aid observation of both intra- and extravascular cells.Cells 2020, 9, x FOR PEER REVIEW 4 of 17 
 
Figure 1. Intravenous transplantation of prostate cancer (PCa) cells induces extravasation and 
perivascular metastasis formation. (a) Schematic indication of cancer cell engraftment. PC-3M-Pro4-
mCherry was injected into zebrafish (ZF) vasculature. Metastases was formed at 6 dpi. Red, cancer 
cells. Green, vessels. (b–c) High-resolution images were acquired using a Light-sheet microscope. 
Scale bar=100 um. (b) Three-dimensional overview of metastatic phenotype of the cancer cells at 6 
dpi. Left, lateral. Middle, posterior. Right, Ventral. Up, solid vessels. Down, transparent vessels. 
Figure 1. Cont.
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Figure 1. Intravenous transplantation of prostate cancer (PCa) cells induces extravasation and
perivascular etastasis for ation. (a) Sche atic indication of cancer cell engraftment. PC-3M-Pro4-
mCherry was injected into zebrafish (ZF) vasculature. etastases was formed at 6 dpi. Red, cancer
cells. Green, vessels. (b–c) igh-resolution images were acquired using a Light-sheet microscope.
Scale bar=100 u . (b) Three-dimensional overview of metastatic phenotype of the cancer cells at
6 dpi. Left, lateral. Middle, posterior. Right, Ventral. Up, solid vessels. Down, transparent vessels.
Imaging was acquired using Zeiss Lightsheet Z1 at 40x magnification. Zeiss ZEN software was used
for multiview fusion and deconvolution. Image J and Imaris 8.1 were applied for imaging stitching
and 3D rendering. (c) High-magnification images to show single cell behaviors. Single cells were
extravasated from intersegmental vessel (ISV), dorsal longitudinal anastomotic vessel (DLV) and Dorsal
vein (DA). Up, solid vessels. Down, transparent vessels. (d–e) Whole-mount immunofluorescence
against phosphorylated Histone 3 (d) and Ki-67 (e) at 6 dpi. Images were acquired using confocal.
Scale bar = 50um.
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2.3. Immunofluorescence
Whole-mount immunofluorescence on ZF was performed as described before [33]. ZF was fixed
with 4% PFA, dehydrated and rehydrated with methanol in series concentration (25%, 50%, 75% and
100%). After permeabilization with 10ug/mL Protease K, embryos were blocked using blocking buffer
containing 0.7%Triton X-100 and 5% sheep serum in 0.5% PBST. After incubation with primary (1/200)
and fluorescence-conjugated secondary (1/200) antibodies, images were acquired using Leica SP8
confocal laser-scanning microscope. Antibodies used in the experiments included mouse anti-vimentin
antibody (ab128507, Abcam, Cambridge, UK), rabbit anti-ki67 antibody (ab16667, Abcam Cambridge,
UK) and rabbit anti-p-Histone3 (sc374669, Santa cruze, Dallas, TX, USA).
2.4. ALDEFLUOR Assay and Fluorescence-Activated Cell Sorting (FACS) Sorting
Cancer cells with high ALDH activity were detected and sorted using an ALDEFLUOR Assay kit
(StemCell technology, Köln, Germany) following the manufacturer’s protocol. Briefly, 1–10 million
PC-3M-Pro4-mCherry cells were treated with the ALDEFLUOR reagent. To set the gate for negative
population, 500,000 PC-3M-Pro4-mCherry cells were treated with ALDEFLUOR reagent together with
DEAB, an ALDH inhibitor. FACSCanto II (BD Biosciences, San Jose, CA, USA) was used for the
measurement, and data were further analyzed with FCS Express Software (De Novo FCS Express 6).
Each condition was independently repeated three times. For whole-mount ALDFLJUOR live staining
on ZF, 6 dpf ZF was embedded in 1% low melting temperature agarose. Concentrated ALDEFLUOR
reagent (10×) in ALDEFLUOR buffer was dropped on ZF. After incubation at 34 ◦C for 1 h, ZF was
immediately imaged using a Leica SP8 confocal laser-scanning microscope.
2.5. RNA Extraction and qPCR
Total RNA isolation from ZF was performed as described before [33]. Metastasis samples in ZF
were collected by cutting the whole metastatic site (80 fish per group) at 6 dpi using a micro dissection
scissor (WPI, FL, USA). After cutting, the samples were immediately washed with cold PBS and stored
in TRIzol (Sigma-Aldrich, Zwijndrecht, Netherlands) at −20 ◦C. The whole process was finished within
30 min. Whole RNA was isolated using the RNeasy mini kit (qiagen) following the manufacturer’s
protocol. iScript™ cDNA Synthesis Kit (Bio-Rad, Utrecht, Netherlands) was used for cDNA synthesis
and iQ™ SYBR®Green Supermix (Bio-Rad, Utrecht, Netherlands) was for qPCR as described in the
manufacturer’s protocol. For each gene analysis, human specific primers were designed in order
to measure the gene expression variation in human cancer cells. The species specificity was tested
before the experiments. GAPDH was included as housekeeping for normalization. Three independent
experiments were performed.
2.6. Lentivirus Production and Transduction
Short hairpin RNA (shRNA) constructs against Cripto-1 (TRCN004890), Snail1 (TRCN0000063818,
TRCN0000063821) and Zeb1 (TRCN0000017565, TRCN0000364631) were obtained from Sigma’s
MISSION library (Kindly provided by the Department of Molecular Cell Biology, LUMC, Leiden,
Netherlands). Lentiviruses were produced by transforming pLenti constructs, packaging plasmids
psPAX2 and enveloped plasmids pMD2.G (Addgene, Watertown, MA, USA) into HEK-293T cells
using lipoD293 (SignaGen Laboratories, Gaithersburg, MD, USA) as transforming reagent. Lentivirus
supernatant was collected at 72 h after transformation. Cells were transduced with the lentiviruses
using 6ug/mL Polybrene (Sigma-Aldrich, Zwijndrecht, Netherlands).
2.7. Statistics
Statistical analysis was performed with Graphpad Prism 7.0 (San Diego, CA, USA). A t-test was
used to compare two groups and ANOVA for multiple groups. Data are presented as mean ±SEM or
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mean ±SD. p-values ≤0.05 are considered to be statistically significant (*p ≤ 0.05, **p < 0.01, ***p < 0.001,
****p < 0.0001)
3. Results
3.1. Intravenous Transplantation of PCa Cancer Cells into Zebrafish Leads to Development of Extravascular
Metastatic Tumor Growth
Androgen-independent osteotropic PC-3M-Pro4-mCherry cells (300–500 cells) were intravenously
injected into the duct of Cuvier (DoC) of tg(Fli:GFP) endothelial reporter transgenic zebrafish line with
fluorescent vasculature at 2 d post fertilization (dpf) (Figure 1a) [32]. DoC is an open blood circulation
channel connecting the heart and the trunk vasculature. Immediately after transplantation, cells
hematogenously disseminated through the whole circulation. Most of the circulating cells regressed
without extravasation and initiating tumor growth. However, exclusively at the posterior ventral
end of caudal hematopoietic tissue (CHT), perivascular cells were able to extravasate and invade
into tail fin within 1 d and developed perivascular metastatic lesions within 6 d (Figure 1a,b). CHT
is a ZF hematopoietic organ at the early developmental stage with a certain molecular and cellular
similarity to mice bone marrow [30,34]. To image cellular details of the metastatic phenotype, at 6 d
post injection (dpi), high-resolution imaging was performed using a Light-sheet Confocal microscope
(Figure 1b,c). This image proved that single cancer cells circulated in the blood flow and extravasated
from intersegmental vessel (ISV), dorsal longitudinal anastomotic vessel (DLV), dorsal vein (DA) and
caudal vein (CV) (Figure 1c). The metastatic tumor growth around CHT was characterized using
immunofluorescence. Abundant phosphorylated Histone3-positive cells and Ki-67-positive cells were
detected (Figure 1d,e), indicating that expended red fluorescent signal is indeed due to proliferation
of PCa cells at the metastatic site. This novel experimental metastatic assay bypasses the primary
tumor stage and intravasation but opens the possibility to image and study the mechanisms controlling
metastatic initiation of PCa cells in a few days, instead of weeks, in rodent models.
3.2. Oesteotropic PCa Cells with Enhanced EMT and CSC Traits Have Stronger Metastatic Potential in ZF
To prove the usefulness of the ZF model, we compared the metastatic capacity of two PCa cell lines:
PC-3 and PC-3M-Pro4. PC-3M-Pro4 is a metastatic subclone of PC-3, derived by four-fold orthotropic
transplantation of PC-3 into mice prostate, endowing the cells with a strong bone metastatic potential
in mice [35]. After intravascular injection into ZF embryos, PC-3 cells were circulating in blood flow
at 1 and 2 d post injection (dpi) (Figure 2a). At 4 dpi, majority of the cells were cleared; however,
a few cells survived and extravasated into the neighboring tissue around CHT (Figure 2a). In contrast,
PC-3M-Pro4 cells docked at CHT at 1 dpi, extravasated and formed experimental metastasis at 4 dpi
(Figure 2a). Extravasations of PC-3 and PC-3M-Pro4 were evaluated by counting the percentage
of ZF with more than one cell extravasated from caudle vein and invaded the neighboring tissue
(Figure 2a,b). PC-3 extravasated only in 5% of the engrafted ZF at 1 dpi, 10% at 2 dpi and 20% at 4 dpi,
but PC-3M-Pro4 extravasated in 10% at 1 dpi and 50% at 2 and 4 dpi (Figure 2b). Metastatic tumor
outgrowth was determined by measuring total fluorescence intensity in the trunk and CHT (Figure 2c).
Total cancer cell burden of PC-3 at the metastatic site decreased over time, while the cancer cell burden
of PC-3M-Pro4 gradually increased and was significantly higher at 2 and 4 dpi then PC-3 (Figure 2c).
Next, we questioned why PC-3M-Pro4 had stronger metastatic potential than PC-3. Gene
signatures for EMT and cancer stemness were analyzed using qPCR. PC-3M-Pro4 cells in culture
had elevated expression of mesenchymal markers N-cadherin, vimentin, twist, zeb1, zeb2 and snail1,
and stemness markers Nanog, Sox2, Klf4, Bmi1 and CD44 (Figure 2d,e). Notably, PC-3M-Pro4 also
exhibited a higher expression of epithelial marker E-cadherin, indicating these cells had a trait of
partial EMT rather than full EMT where the expression of E-cadherin is missing. Those data suggest
that enhanced metastatic capacity of PC-3M-Pro4 in zebrafish and mice models relies on the elevated
expression of stemness and EMT genes.
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images were acquired at the etastatic site at 1, 2 and 4 dpi. Green, vessels. Red, cancer cells.
Scale bar=50um. (b–c) Extravasation and cancer cell burden at the metastatic site were analyzed.
For extravasation analysis, % of ZF with more than 1 cell extravasated from the caudal vein and
invaded into neighboring tissue was counted. For cancer cell burden quantification, total fluorescence
of mCherry was measured using a ZF-4 pixel counting software. Experiment was independently
repeated 2 times with 30 fish per group. Error bar presented as mean ±SEM. (d–e) The expression
of EMT markers and stemness markers in PC-3 and PC-3M-Pro4 in culture was measured by qPCR.
Experiment was independently repeated 3 times. Data were presented as mean ± SD.
3.3. Metastatic Outgrowth of PCa Cells in ZF is Associated with an Increase of EMT and Cancer
Stemness Markers
We next measured how human cancer cells responded to the ZF microenvironment during the
formation of metastatic lesions at the CHT area. At 6 dpi, RNA samples were collected from the
metastatic lesions formed by PC-3M-Pro4 in 210 ZF embryos (Figure 3a). qPCR was performed using
human specific primers without cross-reactivity with ZF tissue to compare gene expression profiles
of the cancer cells in metastases and in cells culture Table S1. Consequently, the cancer cells from
metastasis exhibited a significantly enhanced expression of mesenchymal marker vimentin, twist and
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zeb2 and a decrease of epithelial marker E-cadherin (Figure 3b). Moreover, these cells also gained
expression of stemness genes including Nanog, Oct4, ALDH7A1 and Cripto (Figure 3c).Cells 2020, 9, x FOR PEER REVIEW 9 of 17 
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Immu ofluorescence against vimentin on PC-3 and PC-3M-Pro4 in ZF metastases. (f–g) ZF engrafted
with PC-3-lifeact-mCherry and PC-3M-Pro4-lifeact-mCherry was stained with ALDEFLUOR reagent
with or without ALDH inhibitor DEAB at 4 dpi. Images were acquired using SP-8 confocal and
processed with Fiji. Scale bar = 50um. Five fish were stained for each group.
In addition, whole-mount immunofluorescence against vimentin was performed on PC-3 and
PC-3M-Pro4 to further examine the EMT features. To visualize overlap between actin cytoskeleton and
vimentin, we transduced PC-3 and PC-3M-Pro4 with Lifeact-mCherry, a small fluorescent peptide
labelling actin filament. In vitro, all PC-3M-Pro4 cells had vimentin expression but only very few
elongated cells in PC-3 expressed vimentin (data not shown). After colonizing ZF CHT at 6 dpi,
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however, both PC-3 and PC-3M-Pro4 displayed extensive and homogeneous expression of vimentin,
indicating an acquisition of EMT features during the metastatic process (Figure 3d,e).
Given that the cancer cell subpopulation with high aldehyde dehydrogenase activity is identified
in vitro as a CSC-enriched cell subpopulation, we applied ALDEFLUOR assay to measure the CSC
features of cells at the metastatic site. At 4 dpi, live ZF engrafted with either PC-3 or PC-3M-Pro4
were stained with ALDEFLUOR reagent, a fluorescence dye labelling viable ALDHhi cells. To set the
negative control, some of the engrafted ZF were treated with the ALDH inhibitor DEAB when exposing
to ALDEFLUOR reagent. Although no or very few ALDH signals were detected in the DEAB-treated
ZF (Figure 3f,g), in DEAB-untreated ZF, both PC-3 and PC-3M-Pro4 exhibited strong ALDH signals
at the metastatic site (Figure 3f,g). Altogether, our data reveal that both PCa cell lines respond to ZF
microenvironment factors, resulting in an enhancement of EMT and CSC markers leading to metastatic
tumor initiation.
3.4. Both ALDHhi and ALDHlow Cells Obtain an Enhanced CSC Trait After Metastatic Colonization
Subsequently, we compared the metastatic potential of PCa CSCs and non-CSCs sorted by
ALDEFLUOR assay from PC-3M-Pro4 (Figure 4a). The aggressiveness of the cells was firstly tested
in vitro. 3D invasion assay was employed by embedding 500 cells into type-I collagen, and the size of
the invasion area was measured after 48 h. In comparison with the ALDHlow cell, the ALDHhi cells
had a significantly enhanced invasive phenotype. (Figure 4b). Clonogenicity assay was employed
to compare self-renewal capacity of the cells by seeding 200 single cells into 6-well plates. After
14 d of growth, significantly more colonies were formed by ALDHhi cells (Figure 4c). Collectively,
those in vitro data indicate that the ALDHhi cells are more invasive and proliferative in vitro than its
ALDHlow counterpart.
We next analyzed the aggressive phenotypes of ALDHhi and ALDHlow cell subpopulations sorted
from PC-3M-Pro4-mCherry in ZF xenografts. After engraftment, the ALDHhi cells extravasated and
invaded in 40% of the engrafted ZF at 1 dpi, while ALDHlow extravasated only in 10% of embryos
(Figure 4d,e). At 2 dpi, the difference of extravasation between two cell types was smaller but still
significant (Figure 4d,e). In addition, cancer cell burden at the metastatic site was measured. ALDHhi
cells had significantly higher cancer cell burden than ALDHlow (Figure 4f). Notably, at 6 dpi, some of
the fish engrafted with ALDHlow still developed metastatic tumor growth; however, it was significantly
lower compared to ALDHhi (Figure 4f). We showed by immunofluorescence that the metastases
formed by both cell subpopulations were rapidly growing, since numerous Ki-67 (proliferation marker)
positive cells were detected in both ALDHhi and ALDHlow cells (Figure 4g).
To assess if the ZF microenvironment can regulate the stemness phenotype of the ALDHhi and/or
ALDHlow cells, ZF engrafted with either ALDHhi or ALDHlow were stained with ALDFLUOR reagent
at 4 dpi. Although extensive ALDEFLUOR signal was detected in the metastases formed by ALDHhi
cells (Figure 4h), some of the ALDHlow cells also displayed the positive ALDEFLUOR signal, indicating
a re-enrichment of the ALDHhi subpopulation in the engrafted ALDHlow cells during metastatic
colonization (Figure 4h).
Furthermore, we compared the expression of stemness genes in two cell subtypes directly after cell
sorting and in metastatic lesions. Before injection, the ALDHhi cells displayed enhanced expression of
stemness markers Nanog, Oct4 and Cripto-1 than the ALDHlow. Surprisingly, at 6 dpi after engraftment
to ZF, the expressions of Nanog, Oct4 and Cripto were significantly increased to a similar level in both
cell subtypes (Figure 4i). Taken together, our results indicate that both ALDHhi and ALDHlow cells can
respond to the microenvironment in ZF, inducing an augment of stemness feature.
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3.5. Knockdown of Cripto Inhibited PCa Cell Metastatic Tumorigenicity Through Suppressing EMT Plasticity
The Nodal signaling co-receptor Cripto has been well documented to play an essential role
in maintaining stemness in both embryonic stem cells and CSCs. In PCa, high expression of
Cripto correlates with poor prognosis and high risk of metastasis in the patients [31]. We have
previously shown that Cripto has a higher expression in ALDHhi subpopulation. The knockdown
of Cripto using shRNA significantly inhibited the size of ALDHhi fraction in vitro and metastasis
in ZF at 4 dpi and mice at 5 weeks after injection, respectively [31]. Here, we further investigated
if microenvironment-induced Cripto was required for the cancer cell plasticity during metastasis
(Figure 4i). To test this, PC-3M-Pro4 cells bearing either SCR or Cripto kd were engrafted into ZF.
As expected, metastatic growth was significantly suppressed by Cripto kd at 6 dpi (Figure 5a). We
collected the metastases tissue and performed cross-species RT-PCR using specific primers (Figure 5b).
The knockdown of Cripto significantly reduced the vimentin/E-cadherin ratio in vivo, indicating that
elevation of Cripto expression in engrafted cells by factors from the metastatic niche was indeed
required for the acquisition of EMT traits during metastatic colonization (Figure 5b).
We next investigated if metastatic growth in the ZF model was regulated by EMT. RNAi was
therefore employed to target the EMT transcriptional factors Snail and Zeb1 to block the EMT trait.
In vitro, the knockdown of Snail1 significantly inhibited vimentin expression but increased E-cadherin
expression, while the knockdown of Zeb1 only enhanced E-cadherin expression without suppressing
vimentin (Figure 5c). When both Snail kd and Zeb1 kd cells were respectively transplanted into ZF,
total cancer burden at the metastatic site was significantly reduced at 6 dpi compared to the SCR
control (Figure 5d), indicating that host microenvironment dependent acquisition of an EMT trait is
essential for metastatic tumor initiation in ZF.Cells 2020, 9, x FOR PEER REVIEW 13 of 17 
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Figure 5. Cripto drives the metastatic phenotype through controlling EMT plasticity. (a) PC-3M-Pro4-
mCherry-SCR and PC-3M-Pro4-mCherry Cripto kd were injected into ZF. Confocal images were acquired
at 6 dpi. Green, vessels. Red, cancer cells. Scale bar = 50um. Cancer cell burden at the metastatic site
was quantified by measuring total fluorescence intensity at 6 dpi. Group size = 30. (b) Expression
of Cripto, stemness markers and EMT markers was measured in PC-3M-Pro4-mCherry-SCR and
PC-3M-Pro4-mCherry-Cripto kd in culture and in ZF metastases at 6 dpi. Experiments were
independently repeated three times. Data were presented as mean ± SD (c) Expression of EMT markers
was compared between PC-3M-Pro4-mCherry-SCR, -Snail1 kd and -Zeb1 kd. Experiments were
independently repeated three times. Data were presented as mean ± SD (d) PC-3M-Pro4-mCherry-SCR,
-Snail1 kd and -Zeb1 kd were injected into ZF. Confocal images were acquired at 1, 4 and 6 dpi. Green,
vessels. Red, cancer cells. Scale bar = 50um. (e) Cancer cell burden at the metastatic site was quantified
by measuring total fluorescence intensity. Group size = 30. Data were presented as mean ± SEM.
4. Discussion
Bone metastasis of PCa is a multiple-step process initiated by a few disseminated cancer cells.
In this research, we established a zebrafish xenograft model to monitor the metastatic behavior of PCa
cells at a single-cell resolution. We showed that human osteotropic, androgen-independent PCa cells
can extravasate, proliferate and form perivascular metastases in 4–6 d. This metastatic behavior was
associated with enhanced EMT and CSC traits in the cancer cells colonizing the zebrafish hematopoietic
niche. Knockdown of Cripto, a Nodal co-receptor that was upregulated by ZF niche microenvironment
in PCa metastasis, significantly inhibited metastatic tumorigenicity through suppression of EMT
plasticity in ZF. In addition, targeting of EMT transcriptional factors in PCa cells prior engraftment
also significantly suppressed metastatic growth at CHT.
Our results indicate that the ZF microenvironment can induce human cancer cell plasticity. This
cancer cell–microenvironment interaction in ZF resembles what happens in mammals [10,11,35]. In mice
xenografts, human PCa cells can target the hematopoietic stem cell niche in bone marrow to establish a
foothold inducing CSC enrichment. This CSC enrichment was partially regulated by osteoblasts [10,35].
When PCa cells were co-cultured with osteoblasts in vitro, the ALDHhi subpopulation was enriched
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accompanied by an elevated expression of Cripto and induction of EMT, leading to an aggressive
phenotype of the cancer cells. Given that the response of the human PCa cells to ZF CHT signals
was similar to the PCa cell response to osteoblasts, the molecular cues driving Cripto expression and
ALDHhi subpopulation enrichment in both conditions seem to be comparable.
Interaction between human cancer cells and ZF microenvironment was described before. CXCL-12,
for instance, is an essential cytokine present in bone marrow leading to bone metastatic colonization
of cancer cells [36]. In ZF, human cancer cells can sense host (ZF) CXCL-12, which is produced by
mesenchymal stem cells in CHT [34], inducing metastatic colonization [29,30]. Targeting of either
CXCR-4 (CXCL-12 receptor) in breast human cancer cells or CXCL-12 in ZF significantly inhibited
extravasation and metastatic tumor growth at the CHT area. In addition, ZF myeloid cells were shown
to guide human cancer cell extravasation and invasion by reorganizing extracellular matrix at the
metastatic site [28]. Moreover, human cancer cells can comparably respond to the ZF microenvironment
of ZF and mice comparably, inducing an activation of NF-kB–Activin A signaling axis which drives
the metastatic CSC-like phenotype of the cancer cells [37]. Taken together, those studies indicated
a functional interaction between human cancer cells and zebrafish microenvironment leading to
the metastatic phenotype. A combination of different platforms including ZF xenografts, osteoblast
co-culturing and mammalian xenografts can, therefore, be employed to study the molecular and
cellular cues driving cancer cell plasticity.
In this research, we addressed how the ZF microenvironment governs metastatic onset of PCa
cells. It was previously reported that Cripto has an enhanced expression in PCa bone metastasis
and correlates with poor prognosis in stratified high-risk patients [31,38]. In PC-3M-Pro4, Cripto
is upregulated in ALDHhi subpopulation in culture and is required for experimental metastasis in
zebrafish and mice xenografts [31]. Here, we showed that Cripto drives PCa cancer metastatic tumor
initiation through induction of EMT at the metastatic onset.
The role of EMT in cancer progression is still under discussion [21]. It was originally recognized
as a driver of cancer cell invasion and metastatic dissemination [39]. After seeding to the niche,
the EMT-reversed program MET is still required to initiate tumor outgrowth [39,40]. As evidence,
metastatic tumor-initiating capacity was diminished after inducing sufficient, irreversible EMT
by ectopic expression of EMT transcriptional factors (TFs), indicating the importance of MET in
metastatic tumor outgrowth [40–42]. In contrast, other researches demonstrated that tumor initiation
was associated with an occurrence of transient EMT, which endowed cancer cells with enhanced
tumor-initiating capacity / CSC traits [19,20]. In prostate cancer, it was suggested that the cells
with EMT status harbor CSC traits, while MET is associated with a more proliferative capacity [43].
Although this research proposed that the heterogenic cell population with a different EMT/MET status
may have distinct functions in metastatic process, due to a limitation of animal models for real-time
single cell tracking, they cannot directly monitor the dynamics of the cell states at the initial stage of
metastatic tumor growth. Here, using ZF xenografts, we observed that both PC-3 and PC-3M-Pro4
obtained enhanced EMT and CSC traits after metastatic seeding. This transient EMT is essential for
metastatic tumor initiation. Targeting of either Snail or Zeb1 to reverse EMT significantly inhibited
metastatic tumorigenicity. To further elucidate how EMT-MET plasticity plays a role in long-term PCa
metastatic tumor outgrowth, as described by others, studies with PCa cell lines bearing EMT reporter
and inducible EMT/MET TFs expression systems can be performed using the immunodeficient ZF
xenograft model [26]. This approach would allow to track single cancer cell EMT plasticity during
whole metastatic cascade in long term.
Overall, in this study we employed a ZF xenograft model to track PCa cell plasticity at the early
stage of metastasis. We showed that the PCa cells at the metastatic site obtained enhanced EMT and
CSC traits, which were partially controlled by the induction of Cripto. Targeting either Cripto or other
EMT factors may, therefore, have significant clinical potential. Moreover, our data highlight that ZF
xenograft model can be applied as a powerful tool to study the role of cancer cell–microenvironment
interactions in cancer stem- and EMT-plasticity regulation.
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29. Tulotta, C.; Ştefănescu, C.; Beletkaia, E.; Bussmann, J.; Tarbashevich, K.; Schmidt, T.; Snaar-Jagalska, B.
Inhibition of signaling between human CXCR4 and zebrafish ligands by the small molecule IT1t impairs the
formation of triple-negative breast cancer early metastases in a zebrafish xenograft model. Dis. Models Mech.
2016, 9, 141–153. [CrossRef]
30. Sacco, A.; Roccaro, A.; Ma, N.; Shi, J.; Mishima, Y.; Moschetta, M.; Chiarini, M.; Munshi, N.; Handin, R.I.;
Ghobrial, I.M. Cancer Cell Dissemination and Homing to the Bone Marrow in a Zebrafish Model. Cancer Res.
2016, 76, 463–471. [CrossRef]
31. Zoni, E.; Chen, L.; Karkampouna, S.; Granchi, Z.; Verhoef, E.I.; La Manna, F.; Kelber, J.; Pelger, R.C.M.;
Henry, M.; Snaar-Jagalska, E.; et al. CRIPTO and its signaling partner GRP78 drive the metastatic phenotype
in human osteotropic prostate cancer. Oncogene 2017, 36, 4739–4749. [CrossRef] [PubMed]
32. Lawson, N.D.; Weinstein, B.M. In Vivo Imaging of Embryonic Vascular Development Using Transgenic
Zebrafish. Dev. Boil. 2002, 248, 307–318. [CrossRef] [PubMed]
33. Chen, L.; Groenewoud, A.; Tulotta, C.; Zoni, E.; Julio, M.K.-D.; Van Der Horst, G.; Van Der Pluijm, G.;
Snaar-Jagalska, B. A zebrafish xenograft model for studying human cancer stem cells in distant metastasis
and therapy response. Methods in Cell Biology 2017, 138, 471–496. [PubMed]
34. Tamplin, O.J.; Durand, E.M.; Carr, L.A.; Childs, S.J.; Hagedorn, E.J.; Li, P.; Yzaguirre, A.D.; Speck, N.A.;
Zon, L.I. Hematopoietic stem cell arrival triggers dynamic remodeling of the perivascular niche. Cell 2015,
160, 241–252. [CrossRef] [PubMed]
Cells 2020, 9, 797 16 of 16
35. Pettaway, C.A.; Pathak, S.; Greene, G.; Ramirez, E.; Wilson, M.R.; Killion, J.J.; Fidler, I.J. Selection of highly
metastatic variants of different human prostatic carcinomas using orthotopic implantation in nude mice.
Clin. Cancer Res. 1996, 2, 1627–1636. [PubMed]
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